Hanne Leth Hillman
Director of Finance/CFO bei BRAIN+ A/S
Profil
Hanne Leth Hillman is currently the Co-Chairman of The Danish Investor Relations Society.
Additionally, she holds the position of Chief Financial Officer & Director at Brain+ A since 2023 and has been the Chief Financial Officer of Nanovi Radiotherapy A since 2017.
Previously, she worked as the VP, Director-Investor Relations & Capital Market at NTG Nordic Transport Group A from 2009 to 2010.
She also worked as an Analyst at Gudme Raaschou Bank A in 2004.
From 2011 to 2016, she served as the Senior VP-Investor Relations & Communications at Zealand Pharma A.
Ms. Hillman holds an MBA from the University of Aarhus.
Aktive Positionen von Hanne Leth Hillman
| Unternehmen | Position | Beginn |
|---|---|---|
| BRAIN+ A/S | Director of Finance/CFO | 01.09.2022 |
| The Danish Investor Relations Society | Chairman | - |
Nanovi Radiotherapy A/S
 Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark. | Director of Finance/CFO | 01.05.2017 |
Ehemalige bekannte Positionen von Hanne Leth Hillman
| Unternehmen | Position | Ende |
|---|---|---|
| ZEALAND PHARMA A/S | Investor Relations Contact | 01.10.2016 |
| Gudme Raaschou Bank A/S | Analyst-Equity | 05.11.2004 |
| NTG NORDIC TRANSPORT GROUP A/S | Investor Relations Contact | - |
Ausbildung von Hanne Leth Hillman
| University of Aarhus | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| NTG NORDIC TRANSPORT GROUP A/S | Transportation |
| ZEALAND PHARMA A/S | Health Technology |
| BRAIN+ A/S | Technology Services |
| Private Unternehmen | 3 |
|---|---|
| The Danish Investor Relations Society | |
| Gudme Raaschou Bank A/S | Finance |
Nanovi Radiotherapy A/S
Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark. | Health Technology |
